cro.directory
← Compare landing

BioDuro-Sundia vs ChemDiv

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioduro-sundia/chemdiv

CategoryBioDuro-SundiaChemDiv
Listed sitecrocro
SummaryBioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.ChemDiv is a fully integrated target-to-clinic CRO offering discovery chemistry, medicinal chemistry, CADD, ADME/DMPK, toxicology, custom synthesis, and integrated drug discovery services across oncology, CNS, infectious disease, cardiometabolic, and immunology indications.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Regulatory Affairs
  • Immunogenicity Assays (ADA / NAb)
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • Safety Pharmacology
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Gene Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Respiratory
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
Locations
  • Headquarters, Irvine, California, United States
  • Headquarters, San Diego, CA, USA
  • Representative - South Korea, Seongnam-si, Gyeongi-do, South Korea
  • Representative - Japan, Tokyo, Tokyo, Japan
  • Representative - China, Shanghai, Shanghai, China
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.